Back to Search
Start Over
Editorial: Drugging p53 for non-cancer diseases.
- Source :
-
Frontiers in pharmacology [Front Pharmacol] 2022 Nov 30; Vol. 13, pp. 1101742. Date of Electronic Publication: 2022 Nov 30 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Details
- Language :
- English
- ISSN :
- 1663-9812
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in pharmacology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 36532782
- Full Text :
- https://doi.org/10.3389/fphar.2022.1101742